The lancet. HIV. 2025 Jun 4:S2352-3018(25)00123-7. doi: 10.1016/S2352-3018(25)00123-7 Q113.02025

Time to say farewell to abacavir?

告别阿巴卡韦的时候到了？ 翻译改进

作者单位 +展开

DOI: 10.1016/S2352-3018(25)00123-7 PMID: 40482661

摘要 中英对照阅读

Copyright © The lancet. HIV. 中文内容为AI机器翻译，仅供参考！

相关内容

• Abacavir for salvage or intensification

  阿巴卡韦用于挽救或强化治疗

  G Torres

  GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies. 1999 Jan;13(1):4-5.

• Report from the 2008 joint ICAAC/IDSA meeting. More data on abacavir/3TC

  2008年美国感染病学会和抗菌剂与化疗会议联合会议报告 有关阿巴卡韦/拉米夫定更多的数据分析

  Paul E Sax

  AIDS clinical care. 2008 Dec;20(12):104.

• Abacavir/lamivudine/zidovudine maintenance after standard induction in antiretroviral therapy-naïve patients: FREE randomized trial interim results

  初始抗逆转录病毒治疗后使用阿巴卡韦/拉米夫定/齐多夫定进行维持治疗：随机对照FREE研究的中期结果

  Herman G Sprenger et al.

  AIDS patient care and STDs. 2010 Jun;24(6):361-6.

• Dolutegravir/abacavir/lamivudine versus current ART in virally suppressed patients (STRIIVING): a 48-week, randomized, non-inferiority, open-label, Phase IIIb study

  拉伏替尼/阿巴卡韦/拉米夫定与当前疗法在病毒抑制患者中的疗效比较（STRIIVING研究）：一项为期48周的随机、非劣效性、开放标签III期试验

  Benoît Trottier et al.

  Antiviral therapy. 2017;22(4):295-305.

• Analysis of the ternary antiretroviral therapy dolutegravir, lamivudine and abacavir using UV spectrophotometry and chemometric tools

  紫外分光光度法结合化学计量学工具分析多替拉韦、拉米夫定和阿巴卡韦三者混合的抗逆转录病毒疗法药物成分

  Ahmed Serag et al.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy. 2022 Jan 5:264:120334.

• Long-term subcutaneous tissue changes among antiretroviral-naive persons initiating stavudine, zidovudine, or abacavir with lamivudine

  拉米夫定联合司他夫定、齐多夫定或阿巴卡韦长期治疗对皮下组织的影响

  Judith C Shlay et al.

  Journal of acquired immune deficiency syndromes (1999). 2008 May 1;48(1):53-62.

• Effectiveness and safety of abacavir, lamivudine, and zidovudine in antiretroviral therapy-naive HIV-infected patients: results from a large multicenter observational cohort

  阿巴卡韦、拉米夫定和齐多夫定治疗初治的HIV感染者：一项大规模队列研究结果

  Juan Berenguer et al.

  Journal of acquired immune deficiency syndromes (1999). 2006 Feb 1;41(2):154-9.

• Antiviral efficacy of abacavir in antiretroviral therapy-experienced adults harbouring HIV-1 with specific patterns of resistance to nucleoside reverse transcriptase inhibitors

  阿巴卡韦对耐药人类免疫缺陷病毒(HIV-1)核苷类逆转录酶抑制剂成人患者的抗病毒疗效

  E Randall Lanier et al.

  Antiviral therapy. 2004 Feb;9(1):37-45.

• Intensification of stable background therapy with abacavir in antiretroviral therapy experienced patients: 48-week data from a randomized, double-blind trial

  一项随机双盲试验的48周数据：在经验抗病毒治疗的患者中，以阿巴卡韦强化稳定背景疗法的效果

  C Katlama et al.

  HIV medicine. 2001 Jan;2(1):27-34.